The World Health Organisation (WHO) has given its stamp of approval to China’s Sinopharm vaccine, the first jab developed by a non-Western country to obtain emergency authorisation.
The official tick offers a guideline to health regulators around the world that the drug is safe and effective and opens the door to it being shipped to poorer countries in the COVAX initiative.
A separate group advising the UN agency on vaccines said it was “very confident” the Sinopharm vaccine protected people ages 18-59.
WHO authorises emergency use of China's Sinopharm vaccine